ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study

被引:84
作者
Singh, Sanjeet Singh Avtaar [1 ,2 ]
Banner, Nicholas R. [3 ]
Rushton, Sally [4 ]
Simon, Andre R. [2 ]
Berry, Colin [2 ,5 ]
Al-Attar, Nawwar [1 ]
机构
[1] Golden Jubilee Natl Hosp, Cardiothorac Surg, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[3] Harefield Hosp, Transplant & Mech Circulatory Support, London, England
[4] NHSBT, Stat & Clin Studies, Bristol, Avon, England
[5] Golden Jubilee Natl Hosp, Res & Dev, Glasgow, Lanark, Scotland
关键词
RED-BLOOD-CELL; HEART-TRANSPLANTATION; CARDIAC TRANSPLANTATION; INTERNATIONAL SOCIETY; UNITED NETWORK; SURVIVAL; MORTALITY; FAILURE; DONOR; TRANSFUSION;
D O I
10.1097/TP.0000000000002220
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Heart transplantation (HTx) remains the most effective long-term treatment for advanced heart failure. Primary graft dysfunction (PGD) continues to be a potentially life-threatening early complication. In 2014, a consensus statement released by International Society for Heart and Lung Transplantation (ISHLT) established diagnostic criteria for PGD. We studied the incidence of PGD across the United Kingdom. Methods. We analyzed the medical records of all adult patients who underwent HTx between October 2012 and October 2015 in the 6 UK heart transplant centers Preoperative donor and recipient characteristics, intraoperative details, and posttransplant complications were compared between the PGD and non-PGD groups using the ISHLT definition. Multivariable analysis was performed using logistic regression. Results. The incidence of ISHLT PGD was 36%. Thirty-day all-cause mortality in those with and without PGD was 31 (19%) versus 13 (4.5%) (P = 0.0001). Donor, recipient, and operative factors associated with PGD were recipient diabetes mellitus (P = 0.031), recipient preoperative bilateral ventricular assist device (P < 0.001), and preoperative extracorporeal membranous oxygenation (P = 0.023), female donor to male recipient sex mismatch (P = 0.007), older donor age (P = 0.010), and intracerebral haemorrhage/thrombosis in donor (P = 0.023). Intraoperatively, implant time (P = 0.017) and bypass time (P < 0.001) were significantly longer in the PGD cohort. Perioperatively, patients with PGD received more blood products (P < 0.001). Risk factors identified by multivariable logistic regression were donor age (P = 0.014), implant time (P = 0.038), female: male mismatch (P = 0.033), recipient diabetes (P = 0.051) and preoperative ventricular assist device/extracorporeal membranous oxygenation support (P = 0.012). Conclusions. This is the first national study to examine the incidence and significance of PGD after HTx using the ISHLT definition. PGD remains a frequent early complication of HTx and is associated with increased mortality.
引用
收藏
页码:336 / 343
页数:8
相关论文
共 45 条
  • [1] Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients
    Al-Sarraf, Nael
    Thalib, Lukman
    Hughes, Anne
    Houlihan, Maighread
    Tolan, Michael
    Young, Vincent
    McGovern, Eillish
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2011, 9 (01) : 104 - 109
  • [2] Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence
    Anselmi, A
    Abbate, A
    Girola, F
    Nasso, G
    Biondi-Zoccai, GGL
    Possati, G
    Gaudino, M
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (03) : 304 - 311
  • [3] The importance of cold and warm cardiac ischemia for survival after heart transplantation
    Banner, Nicholas R.
    Thomas, Helen L.
    Curnow, Elinor
    Hussey, Julie C.
    Rogers, Chris A.
    Bonser, Robert S.
    [J]. TRANSPLANTATION, 2008, 86 (04) : 542 - 547
  • [4] Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
    Bernardo, Bianca C.
    Weeks, Kate L.
    Pretorius, Lynette
    McMullen, Julie R.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2010, 128 (01) : 191 - 227
  • [5] The Relationship of Left Ventricular Mass and Geometry to Incident Cardiovascular Events
    Bluemke, David A.
    Kronmal, Richard A.
    Lima, Joao A. C.
    Liu, Kiang
    Olson, Jean
    Burke, Gregory L.
    Folsom, Aaron R.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (25) : 2148 - 2155
  • [6] Biochemistry and molecular cell biology of diabetic complications
    Brownlee, M
    [J]. NATURE, 2001, 414 (6865) : 813 - 820
  • [7] Heart Rate After Cardiac Transplantation-Lessons From the Tortoise and the Shrew
    Critchley, William R.
    Yonan, Nizar
    Shaw, Steven M.
    Fildes, James E.
    [J]. TRANSPLANTATION, 2013, 95 (02) : 259 - 265
  • [8] Predictive risk factors for primary graft failure requiring temporary extra-corporeal membrane oxygenation support after cardiac transplantation in adults
    D'Alessandro, Cosimo
    Golmard, Jean-Louis
    Barreda, Eleodoro
    Laali, Mojgan
    Makris, Ralouka
    Luyt, Charles-Edouard
    Leprince, Pascal
    Pavie, Alain
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (04) : 962 - 969
  • [9] A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion
    d'Almeida, MS
    Jagger, J
    Duggan, M
    White, M
    Ellis, C
    Chin-Yee, IH
    [J]. TRANSFUSION MEDICINE, 2000, 10 (04) : 291 - 303
  • [10] Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition
    Dronavalli, Vamsidhar B.
    Rogers, Chris A.
    Banner, Nicholas R.
    [J]. TRANSPLANTATION, 2015, 99 (09) : 1919 - 1925